Market revenue in 2023 | USD 1,134.3 million |
Market revenue in 2030 | USD 1,675.9 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 73.62% in 2023. Horizon Databook has segmented the France high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of various companies producing small-scale HPAPI such as Seqens CDMO, which provides custom HPAPI manufacturing, is expected to fuel the market growth in the country. According to World Bank, in 2018, over 20% of the French population is aged over 65.
In a country with a population of 67 million individuals, 1 in 5 individuals is aged above 65. In addition, the incidence of cancer is increasing rapidly. France recorded a 93% growth rate in cancer in women from 1990 to 2018.
Nearly 45% of overall cancer cases are of lung cancer. Large population of smokers and growing geriatric population are leading to an increase in the prevalence of cancer in the region. This is anticipated to boost the demand for anti-cancer drugs, thereby fueling the growth of high potency active pharmaceutical ingredients market.
Horizon Databook provides a detailed overview of country-level data and insights on the France high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into France high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account